Cargando…

Psychopharmacologic treatment of borderline personality disorder

The best available evidence for psychopharmacologic treatment of borderline personality disorder (BPD) is outlined here. BPD is defined by disturbances in identity and interpersonal functioning, and patients report potential medication treatment targets such as impulsivity, aggression, transient psy...

Descripción completa

Detalles Bibliográficos
Autor principal:	Ripoll, Luis H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Les Laboratoires Servier 2013
Materias:	Treatment Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3811092/ https://www.ncbi.nlm.nih.gov/pubmed/24174895

Ejemplares similares

Current Clinical Psychopharmacology in Borderline Personality Disorder
por: Del Casale, Antonio, et al.
Publicado: (2021)

The Psychopharmacology of Agitation: Consensus Statement of the American Association for Emergency Psychiatry Project BETA Psychopharmacology Workgroup
por: Wilson, Michael P, et al.
Publicado: (2012)

Awareness and Treatment of Alcohol Dependence in Japan: Results from Internet-Based Surveys in Persons, Family, Physicians and Society
por: Taguchi, Yurie, et al.
Publicado: (2014)

Psychopharmacology of anxiety disorders
por: Cassano, Giovanni B., et al.
Publicado: (2002)

Dental management of patients with substance use disorder
por: Cuberos, Mara, et al.
Publicado: (2020)

Psychopharmacological Treatment of Obsessive-Compulsive Disorder (OCD)
por: Del Casale, Antonio, et al.
Publicado: (2019)

An Update on Psychopharmacological Treatment of Autism Spectrum Disorder
por: Aishworiya, Ramkumar, et al.
Publicado: (2022)

Psychopharmacological treatment in dissociative identity disorder (DID)
por: Pinilla, R., et al.
Publicado: (2021)

Psychopharmacology
por: McInerney, Shane, et al.
Publicado: (2014)

Twelve-Month Follow-up Results from a Randomized Controlled Trial of a Brief Personalized Feedback Intervention for Problem Drinkers
por: Cunningham, John A., et al.
Publicado: (2010)

Associations between antipsychotics and risk of violent crimes and suicidal behaviour in personality disorder
por: Herttua, Kimmo, et al.
Publicado: (2022)

Psychopharmacology
Publicado: (1989)

Psychopharmacology
por: Pitt, Brice
Publicado: (1968)

Brain Structural Effects of Psychopharmacological Treatment in Bipolar Disorder
por: McDonald, Colm
Publicado: (2015)

Benefit of burosumab in adults with X-linked hypophosphataemia (XLH) is maintained with long-term treatment
por: Kamenicky, Peter, et al.
Publicado: (2023)

Treatment of severe borderline personality disorder with clozapine
por: Vohra, Adarsh Kumar
Publicado: (2010)

What Works in the Treatment of Borderline Personality Disorder
por: Choi-Kain, Lois W., et al.
Publicado: (2017)

The outcomes of home treatment for borderline personality disorder
por: Turhan, Sibel, et al.
Publicado: (2016)

The use of borderline personality disorder severity index-iv feedback in adjusting borderline personality disorder treatment: therapists and patients perspectives
por: de Wilde Brand, Odette, et al.
Publicado: (2022)

The Psychopharmacology of Lithium
por: Krystal, John H.
Publicado: (1986)

Treatment of functional mitral regurgitation by percutaneous annuloplasty: results of the TITAN Trial
por: Siminiak, Tomasz, et al.
Publicado: (2012)

Severe inpatient hypertension prevalence and blood pressure response to antihypertensive treatment
por: Ghazi, Lama, et al.
Publicado: (2022)

Suicidality in Borderline Personality Disorder
por: Paris, Joel
Publicado: (2019)

Treatment retention of infliximab and etanercept originators versus their corresponding biosimilars: Nordic collaborative observational study of 2334 biologics naïve patients with spondyloarthritis
por: Lindström, Ulf, et al.
Publicado: (2019)

Applications of transcranial magnetic stimulation and magnetic seizure therapy in the study and treatment of disorders related to cerebral aging
por: Luber, Bruce, et al.
Publicado: (2013)

Monotherapy treatment with chlorthalidone or amlodipine in the systolic blood pressure intervention trial (SPRINT)
por: Vakil, Deep, et al.
Publicado: (2021)

Resistance to antihypertensive treatment and long‐term risk: The Atherosclerosis Risk in Communities study
por: Wijkman, Magnus O., et al.
Publicado: (2021)

Navigating the Alcohol Treatment Pathway: A Qualitative Study from the Service Users' Perspective
por: Gilburt, Helen, et al.
Publicado: (2015)

Massive nodulous lesions on hands and feet in a RA patient and improvement under baricitinib treatment
por: Valor-Méndez, Larissa, et al.
Publicado: (2020)

Social Judgement in Borderline Personality Disorder
por: Nicol, Katie, et al.
Publicado: (2013)

Burosumab treatment in adults with X-linked hypophosphataemia: 96-week patient-reported outcomes and ambulatory function from a randomised phase 3 trial and open-label extension
por: Briot, Karine, et al.
Publicado: (2021)

ADHD in adolescents with borderline personality disorder
por: Speranza, Mario, et al.
Publicado: (2011)

Splitting in Schizophrenia and Borderline Personality Disorder
por: Pec, Ondrej, et al.
Publicado: (2014)

Regulation of peripheral classical and non-classical monocytes on infliximab treatment in patients with rheumatoid arthritis and ankylosing spondylitis
por: Aeberli, Daniel, et al.
Publicado: (2016)

Suprascapular nerve block for the treatment of adhesive capsulitis: a randomised double-blind placebo-controlled trial
por: Shanahan, E Michael, et al.
Publicado: (2022)

Incidence of facial nerve palsies stratified by DMARD treatment in patients with rheumatoid arthritis: data from the RABBIT register
por: Meissner, Yvette, et al.
Publicado: (2020)

A double‐blind, placebo‐controlled trial on the antihypertensive treatment effect of a quadruple single‐pill combination
por: Hu, Lei‐Xiao, et al.
Publicado: (2021)

Treatment of borderline personality disorder and co-occurring anxiety disorders
por: Harned, Melanie S., et al.
Publicado: (2013)

Evolution in the Treatment of Psychiatric Disorders: From Psychosurgery to Psychopharmacology to Neuromodulation
por: Staudt, Michael D., et al.
Publicado: (2019)

Treatment of hypertension with angiotensin‐converting enzyme inhibitors or angiotensin receptor blockers and resting metabolic rate: A cross‐sectional study
por: Pedrianes‐Martin, Pablo B., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_23l736f2t4ok0voi5vu2mf5cse